155 related articles for article (PubMed ID: 7192154)
1. Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces.
Hamblin TJ; Abdul-Ahad AK; Gordon J; Stevenson FK; Stevenson GT
Br J Cancer; 1980 Oct; 42(4):495-502. PubMed ID: 7192154
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibody.
Gordon J; Abdul-Ahad AK; Hamblin TJ; Stevenson FK; Stevenson GT
Br J Cancer; 1984 May; 49(5):547-57. PubMed ID: 6722005
[TBL] [Abstract][Full Text] [Related]
3. Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation.
Stevenson FK; Gordon J
J Immunol; 1983 Feb; 130(2):970-3. PubMed ID: 6600259
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytes.
Tutt AL; Stevenson FK; Smith JL; Stevenson GT
J Immunol; 1983 Dec; 131(6):3058-63. PubMed ID: 6417240
[TBL] [Abstract][Full Text] [Related]
5. The nature of the immunoglobulin G on the surface of B lymphocytes in chronic lymphocytic leukemia.
Stevenson FK; Hamblin TJ; Stevenson GT
J Exp Med; 1981 Dec; 154(6):1965-9. PubMed ID: 6976409
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic lymphocytic leukaemia with monoclonal anti-idiotypic antibody.
Capel PJ; Preijers FW; Allebes WA; Haanen C
Neth J Med; 1985; 28(3):112-8. PubMed ID: 3982571
[No Abstract] [Full Text] [Related]
7. BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor.
Krolick KA; Isakson PC; Uhr JW; Vitetta ES
Immunol Rev; 1979; 48():81-106. PubMed ID: 94899
[No Abstract] [Full Text] [Related]
8. In vitro idiotypic suppression of chronic lymphocytic leukemia lymphocytes secreting monoclonal immunoglobulin M anti-sheep erythrocyte antibody.
Bona CA; Fauci AS
J Clin Invest; 1980 Mar; 65(3):761-7. PubMed ID: 6986413
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
Moshitzky S; Kukulansky T; Haimovich J; Hollander N
Immunol Cell Biol; 2008; 86(3):261-7. PubMed ID: 18195726
[TBL] [Abstract][Full Text] [Related]
10. Preferential expression of IgG1 antibodies specific for L2C leukaemia IgM idiotypic determinants in tumour-protected strain 2 guinea-pigs.
Ricardo MJ; Grimm DT
Immunology; 1983 Apr; 48(4):763-9. PubMed ID: 6187671
[TBL] [Abstract][Full Text] [Related]
11. The expression and functional involvement of nuclease- specific idiotype on nuclease-primed helper T cells.
Nadler PI; Miller GG; Sachs DH; Hodes RJ
Eur J Immunol; 1982 Feb; 12(2):113-20. PubMed ID: 6281025
[TBL] [Abstract][Full Text] [Related]
12. Secretion of immunoglobulin by neoplastic B lymphocytes from lymph nodes of patients with lymphoma.
Stevenson FK; Gregg EO; Smith JL; Stevenson GT
Br J Cancer; 1984 Nov; 50(5):579-86. PubMed ID: 6333886
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants.
George AJ; McBride HM; Glennie MJ; Smith LJ; Stevenson FK
Hybridoma; 1991 Apr; 10(2):219-27. PubMed ID: 1908435
[TBL] [Abstract][Full Text] [Related]
14. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
Kwak LW; Campbell M; Levy R
Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
[TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
George AJ; Tutt AL; Stevenson FK
J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
[TBL] [Abstract][Full Text] [Related]
16. Treatment of lymphoid tumors with anti-idiotype antibodies.
Stevenson GT; Stevenson FK
Springer Semin Immunopathol; 1983; 6(1):99-115. PubMed ID: 6351310
[No Abstract] [Full Text] [Related]
17. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies.
Meeker T; Lowder J; Cleary ML; Stewart S; Warnke R; Sklar J; Levy R
N Engl J Med; 1985 Jun; 312(26):1658-65. PubMed ID: 3923352
[TBL] [Abstract][Full Text] [Related]
18. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
Qian GX; Fu SM; Solanki DL; Rai KR
J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
[TBL] [Abstract][Full Text] [Related]
19. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.
Kwak LW; Campbell MJ; Czerwinski DK; Hart S; Miller RA; Levy R
N Engl J Med; 1992 Oct; 327(17):1209-15. PubMed ID: 1406793
[TBL] [Abstract][Full Text] [Related]
20. [The anticomplementary activity of 2 intravenous gamma globulin preparations in children with acute lymphatic leukemia].
Wahn V; von Kries R; Ebell W; Jürgens H; Göbel U
Immun Infekt; 1984 Apr; 12(2):115-8. PubMed ID: 6442915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
